Evogene (EVGN) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Evogene (EVGN) over the last 15 years, with Q3 2025 value amounting to -$14.6 million.
- Evogene's Enterprise Value fell 33401.54% to -$14.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.6 million, marking a year-over-year decrease of 33401.54%. This contributed to the annual value of $978000.0 for FY2024, which is 10677.71% up from last year.
- As of Q3 2025, Evogene's Enterprise Value stood at -$14.6 million, which was down 33401.54% from -$2.7 million recorded in Q2 2025.
- Evogene's Enterprise Value's 5-year high stood at -$2.7 million during Q2 2025, with a 5-year trough of -$46.0 million in Q2 2021.
- Its 5-year average for Enterprise Value is -$23.2 million, with a median of -$23.7 million in 2023.
- Its Enterprise Value has fluctuated over the past 5 years, first surged by 9125.65% in 2024, then crashed by 33401.54% in 2025.
- Evogene's Enterprise Value (Quarter) stood at -$38.0 million in 2021, then rose by 15.25% to -$32.2 million in 2022, then surged by 55.16% to -$14.4 million in 2023, then decreased by 16.97% to -$16.9 million in 2024, then rose by 13.3% to -$14.6 million in 2025.
- Its Enterprise Value was -$14.6 million in Q3 2025, compared to -$2.7 million in Q2 2025 and -$10.3 million in Q1 2025.